 |
Madrigal Pharmaceuticals
Last updated: May 04, 2024
Madrigal leaders: Drs. Paul Friedman and Rebecca Taub
Country: USA | Funding: $1.5B (+)
Website: http://madrigalpharma.com/
The Company is targeting treatment of both niche and prevalent indications, including fatty liver disease.
Website: http://madrigalpharma.com/
The Company is targeting treatment of both niche and prevalent indications, including fatty liver disease.
